Intrinsic Value of S&P & Nasdaq Contact Us

Viridian Therapeutics, Inc. VRDN

NASDAQ Capital Marke

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$43.10
+183.7%

Viridian Therapeutics, Inc. (VRDN) current share price is $15.19. The gold spot price is $4,808.10 per troy ounce. Using the formula: VRDN in gold = $15.19 × 31.1035 ÷ $4,808.10 = 0.0983 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of VRDN when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding VRDN shares over the measured period.

VRDN in US Dollars
Gold in US Dollars
VRDN in Gold (grams per share)

Real Wealth Growth Rate

VRDN
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{VRDN}_{\text{gold}}(t) = \frac{P_{\text{VRDN}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{VRDN}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{VRDN}_{\text{gold}}^{(T)}}{\text{VRDN}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{VRDN}_\text{gold}^{(0)}$ = initial gold-price, $\text{VRDN}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

RVMD
RVMD
Revolution Medicines, Inc.
$147.01
+7.86%
PCVX
PCVX
Vaxcyte, Inc.
$62.76
+1.64%
BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
CERE
CERE
Cerevel Therapeutics Holdings, Inc.
$44.96
+0.74%
CYTK
CYTK
Cytokinetics, Incorporated
$66.35
-0.55%
NUVL
NUVL
Nuvalent, Inc.
$105.02
+1.28%
MRUS
MRUS
Merus N.V.
$90.00
+0.00%
ACLX
ACLX
Arcellx, Inc.
$114.89
+0.02%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message